NEUROCRINE BIOSCIENCES INC Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Neurocrine Biosciences Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Neurocrine Biosciences Inc Return On Equity for the quarter ending September 30, 2024 was 15.7 %, a 48.8% increase year-over-year.
  • Neurocrine Biosciences Inc annual Return On Equity for 2023 was 12.9 %, a 26.2% increase from 2022.
  • Neurocrine Biosciences Inc annual Return On Equity for 2022 was 10.2 %, a 47.9% increase from 2021.
  • Neurocrine Biosciences Inc annual Return On Equity for 2021 was 6.89 %, a 85.4% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 12.9 +2.67 +26.2% Jan 1, 2023 Dec 31, 2023
2022 10.2 +3.3 +47.9% Jan 1, 2022 Dec 31, 2022
2021 6.89 -40.2 -85.4% Jan 1, 2021 Dec 31, 2021
2020 47.1 +40 +569% Jan 1, 2020 Dec 31, 2020
2019 7.03 +1.98 +39.2% Jan 1, 2019 Dec 31, 2019
2018 5.05 +48.5 Jan 1, 2018 Dec 31, 2018
2017 -43.5 -4.81 -12.4% Jan 1, 2017 Dec 31, 2017
2016 -38.6 -19.1 -98% Jan 1, 2016 Dec 31, 2016
2015 -19.5 +6.91 +26.2% Jan 1, 2015 Dec 31, 2015
2014 -26.4 +8.32 +23.9% Jan 1, 2014 Dec 31, 2014
2013 -34.7 -38.2 -1113% Jan 1, 2013 Dec 31, 2013
2012 3.43 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.